BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou J, Zhao W, Wu J, Lu J, Ding Y, Wu S, Wang H, Ding D, Mo F, Zhou Z, Teng L, Chen S. Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric Cancer. Biomed Res Int 2019;2019:8103142. [PMID: 31312661 DOI: 10.1155/2019/8103142] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Dhanda SK, Mahajan S, Manoharan M. Neoepitopes prediction strategies: an integration of cancer genomics and immunoinformatics approaches. Brief Funct Genomics 2023;22:1-8. [PMID: 36398967 DOI: 10.1093/bfgp/elac041] [Reference Citation Analysis]
2 Eshkiki ZS, Agah S, Tabaeian SP, Sedaghat M, Dana F, Talebi A, Akbari A. Neoantigens and their clinical applications in human gastrointestinal cancers. World J Surg Oncol 2022;20:321. [PMID: 36171610 DOI: 10.1186/s12957-022-02776-y] [Reference Citation Analysis]
3 Yu X, He S, Shen J, Huang Q, Yang P, Huang L, Pu D, Wang L, Li L, Liu J, Liu Z, Zhu L. Tumor vessel normalization and immunotherapy in gastric cancer. Ther Adv Med Oncol 2022;14:17588359221110176. [PMID: 35872968 DOI: 10.1177/17588359221110176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Moradi N, Ohadian Moghadam S, Heidarzadeh S. Application of next-generation sequencing in the diagnosis of gastric cancer. Scand J Gastroenterol 2022;57:842-55. [PMID: 35293278 DOI: 10.1080/00365521.2022.2041717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yuan Y, Chen C, Liu S, Xiong H, Huang Y, Zhang X, Zhang X, Li B. Identification of shared neoantigens in esophageal carcinoma by the combination of comprehensive analysis of genomic data and in silico neoantigen prediction. Cellular Immunology 2022. [DOI: 10.1016/j.cellimm.2022.104537] [Reference Citation Analysis]
6 Zhou S, Liu S, Zhao L, Sun HX. A Comprehensive Survey of Genomic Mutations in Breast Cancer Reveals Recurrent Neoantigens as Potential Therapeutic Targets. Front Oncol 2022;12:786438. [PMID: 35387130 DOI: 10.3389/fonc.2022.786438] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Niu P, Huang H, Zhao L, Wang T, Zhang X, Wang W, Zhang Y, Guo C, Zhao D, Chen Y. Clinicopathological characteristics, survival outcomes, and genetic alterations of younger patients with gastric cancer: Results from the China National Cancer Center and cBioPortal datasets. Cancer Medicine. [DOI: 10.1002/cam4.4669] [Reference Citation Analysis]
8 Animesh S, Ren X, An O, Chen K, Lee SC, Yang H, Fullwood MJ. Exploring the Neoantigen burden in Breast Carcinoma Patients.. [DOI: 10.1101/2022.03.03.482669] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 de Sousa E, Lérias JR, Beltran A, Paraschoudi G, Condeço C, Kamiki J, António PA, Figueiredo N, Carvalho C, Castillo-Martin M, Wang Z, Ligeiro D, Rao M, Maeurer M. Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery. Front Immunol 2021;12:592031. [PMID: 34335558 DOI: 10.3389/fimmu.2021.592031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Pop L, Zanoaga O, Chiroi P, Nutu A, S. Korban S, Stefan C, Irimie A, Berindan-neagoe I. Microarrays and NGS for Drug Discovery. Drug Design - Novel Advances in the Omics Field and Applications 2021. [DOI: 10.5772/intechopen.96657] [Reference Citation Analysis]
11 Wang H, Ding Y, Chen Y, Jiang J, Chen Y, Lu J, Kong M, Mo F, Huang Y, Zhao W, Fang P, Chen X, Teng X, Xu N, Lu Y, Yu X, Li Z, Zhang J, Wang H, Bao X, Zhou D, Chi Y, Zhou T, Zhou Z, Chen S, Teng L. A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics. Gastric Cancer 2021. [PMID: 34095982 DOI: 10.1007/s10120-021-01201-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
12 Choi E, Park SJ, Lee G, Yoon SK, Lee M, Lee SK. The GNAQ T96S Mutation Affects Cell Signaling and Enhances the Oncogenic Properties of Hepatocellular Carcinoma. Int J Mol Sci 2021;22:3284. [PMID: 33807071 DOI: 10.3390/ijms22063284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Gopanenko AV, Kosobokova EN, Kosorukov VS. Main Strategies for the Identification of Neoantigens. Cancers (Basel) 2020;12:E2879. [PMID: 33036391 DOI: 10.3390/cancers12102879] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
14 Wu W, Chen Y, Huang L, Li W, Tao C, Shen H. Point mutation screening of tumor neoantigens and peptide-induced specific cytotoxic T lymphocytes using The Cancer Genome Atlas database. Oncol Lett 2020;20:123. [PMID: 32934692 DOI: 10.3892/ol.2020.11986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Chen C, Liu S, Qu R, Li B. Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets. Biomed Res Int 2020;2020:2861240. [PMID: 32733937 DOI: 10.1155/2020/2861240] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
16 Moradi A, Pourseif MM, Jafari B, Parvizpour S, Omidi Y. Nanobody-based therapeutics against colorectal cancer: Precision therapies based on the personal mutanome profile and tumor neoantigens. Pharmacological Research 2020;156:104790. [DOI: 10.1016/j.phrs.2020.104790] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
17 Gaeta R, Lessi F, Mazzanti C, Modena M, Garaventa A, Boero S, Michelis MB, Capanna R, Aretini P, Franchi A. Diffuse bone and soft tissue angiomatosis with GNAQ mutation. Pathol Int 2020;70:452-7. [PMID: 32314513 DOI: 10.1111/pin.12933] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Wu J, Chen Z, Song Y, Zhu Y, Dou G, Shen X, Zhou Y, Jiang H, Li J, Peng Y. CircRNA_0005075 suppresses carcinogenesis via regulating miR-431/p53/epithelial-mesenchymal transition axis in gastric cancer. Cell Biochem Funct 2020;38:932-42. [PMID: 32133664 DOI: 10.1002/cbf.3519] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
19 Chen C, Zhou Q, Wu R, Li B, Chen Q, Zhang X, Shi C. A Comprehensive Survey of Genomic Alterations in Gastric Cancer Reveals Recurrent Neoantigens as Potential Therapeutic Targets. Biomed Res Int 2019;2019:2183510. [PMID: 31781598 DOI: 10.1155/2019/2183510] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]